ConductScience.org, home

Paper308506

Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.

Drasar FA and 5 others. J Antimicrob Chemother, 1978. Cited by 81 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. Papers, record 308506. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/308506

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
5.45
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Drasar FAF A
2Farrell WW
3Howard AJA J
4Hince CC
5Leung TT
6Williams JDJ D

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacteroides fragilisMajor topic
CephalosporinsMajor topic
EnterobacteriaceaeMajor topic
Gram-Negative Aerobic BacteriaMajor topic
Haemophilus influenzaeMajor topic
Microbial Sensitivity Tests

Source PubMed

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
7,352,752Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7352752PubMed
7,325,628Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325628PubMed
7,247,361Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247361PubMed
6,611,136Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6611136PubMed
6,456,889Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.Drugs1981https://conductscience.org/library/papers/6456889PubMed
6,323,173Serum and cerebrospinal fluid levels of cefotaxime in neurosurgical patients.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6323173PubMed
6,322,676Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6322676PubMed
6,303,743Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs1983https://conductscience.org/library/papers/6303743PubMed
6,293,978Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.Infection1982https://conductscience.org/library/papers/6293978PubMed
6,285,810Cefotaxime therapy of serious bacterial infection in adults.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6285810PubMed
6,282,202Clinical efficacy of cefotaxime in serious infections.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6282202PubMed
6,282,194Clinical pharmacology of cefotaxime in pediatric patients.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6282194PubMed
6,252,830Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252830PubMed
6,252,829Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252829PubMed
6,251,750Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6251750PubMed
6,251,749In vitro antimicrobial activity of cefotaxime, a new cephalosporin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6251749PubMed
6,250,465Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6250465PubMed
6,089,653Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6089653PubMed
4,083,862Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4083862PubMed
4,057,054The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/4057054PubMed

See all 30 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/308506

GET https://conductscience.org/api/papers/v1/308506/cited_by?page=2